These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 33155224)
1. Current views of diabetic peripheral neuropathic pain comorbid depression - a review. Wei KS; Gu MZ; Zhu JW; Hu HC; Yin LP Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10663-10670. PubMed ID: 33155224 [TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of galanin system on diabetic peripheral neuropathic pain and its complications. Yu M; Fang P; Wang H; Shen G; Zhang Z; Tang Z Peptides; 2020 Dec; 134():170404. PubMed ID: 32898581 [TBL] [Abstract][Full Text] [Related]
3. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain. Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204 [TBL] [Abstract][Full Text] [Related]
4. Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States. Yang M; Qian C; Liu Y Pain Med; 2015 Nov; 16(11):2075-83. PubMed ID: 26118704 [TBL] [Abstract][Full Text] [Related]
5. Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies. Wu N; Chen SY; Hallett LA; Boulanger L; Fraser KA; Patel CK; Zhao Y Pain Pract; 2011; 11(1):48-56. PubMed ID: 20602718 [TBL] [Abstract][Full Text] [Related]
7. Use of anticonvulsants drugs for neuropathic painful conditions. Hussain AM; Afshan G J Pak Med Assoc; 2008 Dec; 58(12):690-6. PubMed ID: 19157324 [TBL] [Abstract][Full Text] [Related]
8. Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy? Marchettini P; Wilhelm S; Petto H; Tesfaye S; Tölle T; Bouhassira D; Freynhagen R; Cruccu G; Lledó A; Choy E; Kosek E; Micó JA; Späth M; Skljarevski V; Lenox-Smith A; Perrot S Eur J Pain; 2016 Mar; 20(3):472-82. PubMed ID: 26311228 [TBL] [Abstract][Full Text] [Related]
9. Activation of K Djouhri L; Malki MI; Zeidan A; Nagi K; Smith T J Drug Target; 2019 Dec; 27(10):1118-1126. PubMed ID: 30995134 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacological treatment of neuropathic pain]. Ollat H Rev Neurol (Paris); 1992; 148(8-9):521-31. PubMed ID: 1337388 [TBL] [Abstract][Full Text] [Related]
15. Advances in the Treatment of Neuropathic Pain. Xu L; Zhang Y; Huang Y Adv Exp Med Biol; 2016; 904():117-29. PubMed ID: 26900067 [TBL] [Abstract][Full Text] [Related]
16. New perspectives on the management of diabetic peripheral neuropathic pain. Jensen TS; Backonja MM; Hernández Jiménez S; Tesfaye S; Valensi P; Ziegler D Diab Vasc Dis Res; 2006 Sep; 3(2):108-19. PubMed ID: 17058631 [TBL] [Abstract][Full Text] [Related]
17. An update on the treatment and management of diabetic peripheral neuropathy. Donnan J; Ledger S CANNT J; 2006; 16(4):32-6; quiz 37-8. PubMed ID: 17252899 [TBL] [Abstract][Full Text] [Related]